Reporter briefing: Patient impacts of tirzepatide shortage resolution
APC's media briefing shared compounders' first-hand stories with more than 30 reporters from across the country. read more →
Be sure your marketing follows these best practices
APC's new guide will help you stay on the right side of laws and regs. read more →
A fake survey from a pharma-funded organization
What the Partnership for Safe Medicines released "Ain't a legitimate survey." read more →
Lots of letters
On the compounding front, the FDA’s inbox is getting quite a workout lately. read more →
Slick new dosing pen for compounders
Love Lifesciences’ UniPen injector pen is not only a Very Big Deal, it's available at a discount for APC PFM members. read more →
FDA says tirzepatide shortage “resolved”
As of this afternoon, the FDA Drug Shortage List is showing that the shortage of tirzepatide injection is “resolved.” Pharmacies must immediately cease preparing and dispensing compounded copies of Mounjaro and Zepbound. read more →
Get yer law and patient safety CE here
We've made the most popular segment of our 15-hour legal course into a standalone 3-hour, on-demand CE program. read more →
Vet compounders: How has GFI 256 changed things?
Simply put, we want to know if you’ve been affected by recent FDA guidance on veterinary compounding. read more →
☞ On deadline? For media inquiries CLICK HERE.
